Pediatric hidradenitis suppurativa publication trends: 2012 to 2022

Sarah E. Park,Terri Shih,Caitlyn Dagenet,Marcia Hogeling,Meagan Hughes,Justin Gillenwater,Vivian Y. Shi,Jennifer L. Hsiao

DOI: https://doi.org/10.1111/pde.15574

IF: 1.997

2024-02-27

Pediatric Dermatology

Abstract:There is a paucity of bibliometric data on pediatric‐focused hidradenitis suppurativa (HS) publications. To better characterize research trends in pediatric HS and gaps in literature, we systematically searched PubMed between 2012 and 2022 for publications on pediatric HS and collected data on study design, topic, country, and level of evidence. Of 109 articles that met inclusion criteria, less than half (44/109, 40.4%) were high level of evidence studies; the most common study types were case reports/series (41/109, 37.6%) and cross‐sectional studies (25/109, 22.9%), and the most common study topics were HS treatments (44/109, 40.4%), comorbidities (20/109, 18.3%), and clinical presentation (14/109, 12.8%). Although there has been expansion of the pediatric HS literature in recent years, our study highlights the need for larger prospective studies and trials to improve our ability to optimally manage pediatric HS patients and identify predictors of disease progression and treatment response.

dermatology,pediatrics